Pillar Pacific Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Pillar Pacific Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$1.59M	Sell	10,405 -589	-5%	-$91.1K	0.12%	117
2020 Q4	$1.72M	Sell	10,994 -4,546	-29%	-$584K	0.14%	112
2020 Q3	$1.78M	Buy	15,540 +110	+0.7%	+$11.9K	0.17%	107
2020 Q2	$1.73M	Buy	15,430 +195	+1%	+$20.7K	0.18%	107
2020 Q1	$1.37M	Buy	15,235 +1,275	+9%	+$125K	0.18%	110
2019 Q4	$1.51M	Sell	13,960 -2,770	-17%	-$296K	0.15%	126
2019 Q3	$1.64M	Sell	16,730 -520	-3%	-$58.6K	0.18%	119
2019 Q2	$2.26M	Sell	17,250 -110	-0.6%	-$14.2K	0.25%	107
2019 Q1	$2.35M	Sell	17,360 -690	-4%	-$85.8K	0.27%	107
2018 Q4	$1.76M	Sell	18,050 -1,445	-7%	-$171K	0.23%	112
2018 Q3	$2.71M	Sell	19,495 -395	-2%	-$49.5K	0.29%	109
2018 Q2	$2.47M	Buy	19,890 +285	+1%	+$33.3K	0.29%	109
2018 Q1	$2.19M	Buy	19,605 +885	+5%	+$106K	0.26%	113
2017 Q4	$2.24M	Sell	18,720 -4,065	-18%	-$495K	0.27%	112
2017 Q3	$3.2M	Buy	22,785 +1,565	+7%	+$213K	0.41%	98
2017 Q2	$2.58M	Buy	21,220 +15	+0.1%	+$1.75K	0.35%	108
2017 Q1	$2.57M	Buy	21,205 +1,242	+6%	+$160K	0.36%	106
2016 Q4	$2.44M	Sell	19,963 -8,055	-29%	-$986K	0.38%	101
2016 Q3	$3.43M	Buy	28,018 +1,558	+6%	+$201K	0.54%	84
2016 Q2	$3.09M	Buy	26,460 +1,198	+5%	+$170K	0.52%	83
2016 Q1	$3.52M	Buy	25,262 +1,625	+7%	+$239K	0.61%	74
2015 Q4	$4.51M	Buy	23,637 +220	+0.9%	+$38.4K	0.81%	49
2015 Q3	$3.66M	Buy	23,417 +795	+4%	+$145K	0.69%	62
2015 Q2	$4.09M	Buy	22,622 +16,410	+264%	+$2.83M	0.71%	65
2015 Q1	$1.08M	Buy	6,212 +375	+6%	+$67.9K	0.19%	117
2014 Q4	$1.08M	Sell	5,837 -13	-0.2%	-$2.41K	0.19%	117
2014 Q3	$971K	Sell	5,850 -295	-5%	-$48.4K	0.18%	117
2014 Q2	$960K	Buy	6,145 +795	+15%	+$126K	0.18%	123
2014 Q1	$814K	Buy	5,350 +360	+7%	+$57.2K	0.17%	124
2013 Q4	$663K	Sell	4,990 -110	-2%	-$13.2K	0.13%	136
2013 Q3	$593K	Buy	5,100 +600	+13%	+$65.8K	0.13%	139
2013 Q2	$415K	Buy	+4,500	New	+$434K	0.1%	157

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pillar Pacific Capital Management's ALXN Position: Q1 2021 in Review

Pillar Pacific Capital Management reduced its Alexion Pharmaceuticals (ALXN) stake by 5.4% in Q1 2021, selling an estimated $91.1K and leaving 10,405 shares worth $1.59M. The position accounts for 0.12% of the portfolio, ranked #117.

Pillar Pacific Capital Management first reported a position in ALXN in Q2 2013 and has held it in 32 quarters since. The position peaked at $4.51M in Q4 2015. 752 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Pillar Pacific Capital Management held 10,405 shares of Alexion Pharmaceuticals worth $1.59M as of Q1 2021.
Pillar Pacific Capital Management sold 589 Alexion Pharmaceuticals shares in Q1 2021, an estimated $91.1K.
Alexion Pharmaceuticals made up 0.12% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #117 holding.
Pillar Pacific Capital Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
Pillar Pacific Capital Management's Alexion Pharmaceuticals position peaked at $4.51M in Q4 2015.
752 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.